LOS GATOS, CA / ACCESS Newswire / May 5, 2026 / Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the first quarter ended March 31, 2026.
Recent Company Highlights
Completed $25 Million registered direct offering of common stock
MST in Gate-All-Around structures has moved into the evaluation phase for customers
Expanded GaN offerings to RF applications demonstrating breakthrough improvements to enhance RF performance
Management Commentary
"We made excellent progress during the first quarter toward adoption of MST by GAA manufacturers, engaging with another of the four companies that manufacture those advanced transistors. At the same time, we expanded our offerings in GaN beyond power applications to RF where we believe we will substantially grow our TAM and deliver highly differentiated device performance on larger-diameter wafers," said Scott Bibaud, President and CEO of Atomera. "We are also very pleased to have closed on a $25 million equity raise which brought our cash, cash equivalents and short-term investments to over $41 million. With this additional capital we are in a strong position to enable our customers to bring MST-enabled products to market."
Financial Results
The Company incurred a net loss of ($6.1) million, or ($0.17) per basic and diluted share in the first quarter of 2026, compared to a net loss of ($5.2) million, or ($0.14) per basic and diluted share, for the first quarter of 2025. Adjusted EBITDA (a non-GAAP financial measure) in the first quarter of 2026 was a loss of ($4.9) million compared to an adjusted EBITDA loss of ($4.4) million in the first quarter of 2025.
The Company had $41.1 million in cash, cash equivalents and short-term investments as of Mar. 31, 2026, compared to $19.2 million as of December 31, 2025.
The total number of shares outstanding was 38.7 million as of Mar. 31, 2026.
First Quarter 2026 Results Webinar
Atomera will host a live video webinar today to discuss its financial results and recent progress.
Date: Tuesday, May 5, 2026
Time: 2:00 p.m. PT (5:00 p.m. ET)
Webcast: Accessible at https://ir.atomera.com
Note about Non-GAAP Financial Measures
In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.
About Atomera Incorporated
Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com.
Safe Harbor
This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues thus subjecting us to all the risks inherent in an early-stage enterprise; (2) the risk that licensees or JDA customers do not advance to royalty-based manufacturing and distribution licenses; (3) our ability to add other licensees and/or JDA customers; (4) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (5) our ability to protect our proprietary technology, trade secrets and knowhow and (6) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on February 24, 2026. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.
-- Financial Tables Follow -
Atomera Incorporated
Condensed Balance Sheets
(in thousands, except per share data)
| March 31, |
|
| December 31, |
| |||
| 2026 |
|
| 2025 |
| |||
| (Unaudited) |
|
|
|
| |||
ASSETS |
|
|
|
|
|
| ||
|
|
|
|
|
| |||
Current assets: |
|
|
|
|
|
| ||
Cash and cash equivalents |
| $ | 14,160 |
|
| $ | 19,210 |
|
Short-term investments |
|
| 26,930 |
|
|
| - |
|
Accounts receivable |
|
| 41 |
|
|
| - |
|
Interest receivable |
|
| 139 |
|
|
| 54 |
|
Prepaid expenses and other current assets |
|
| 788 |
|
|
| 338 |
|
Total current assets |
|
| 42,058 |
|
|
| 19,602 |
|
|
|
|
|
|
|
|
| |
Property and equipment, net |
|
| 51 |
|
|
| 60 |
|
Security deposit |
|
| 14 |
|
|
| 14 |
|
Operating lease right-of-use asset |
|
| 1,176 |
|
|
| 884 |
|
Financing lease right-of-use-asset |
|
| 322 |
|
|
| 533 |
|
|
|
|
|
|
|
|
| |
Total assets |
| $ | 43,621 |
|
| $ | 21,093 |
|
|
|
|
|
|
|
|
| |
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
| $ | 677 |
|
| $ | 608 |
|
Accrued expenses |
|
| 213 |
|
|
| 168 |
|
Accrued payroll related expenses |
|
| 782 |
|
|
| 650 |
|
Current operating lease liability |
|
| 301 |
|
|
| 147 |
|
Current financing lease liability |
|
| 106 |
|
|
| 420 |
|
Deferred Revenue |
|
| 96 |
|
|
| 7 |
|
Total current liabilities |
|
| 2,175 |
|
|
| 2,000 |
|
|
|
|
|
|
|
|
| |
Long-term operating lease liability |
|
| 896 |
|
|
| 712 |
|
|
|
|
|
|
|
|
| |
Total liabilities |
|
| 3,071 |
|
|
| 2,712 |
|
|
|
|
|
|
|
|
| |
Commitments and contingencies |
|
| - |
|
|
| - |
|
|
|
|
|
|
|
|
| |
Stockholders' equity: |
|
| - |
|
|
| - |
|
Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding as of March 31, 2026 and December 31, 2025 |
|
|
|
|
|
|
|
|
Common stock: $0.001 par value, authorized 47,500 shares; 38,723 shares issued and 38,716 outstanding as of March 31, 2026; and 32,354 shares issued and outstanding as of December 31, 2025 |
|
| 39 |
|
|
| 32 |
|
Additional paid in capital |
|
| 288,301 |
|
|
| 260,043 |
|
Other comprehensive income (loss) |
|
| (23 | ) |
|
| - |
|
Accumulated deficit |
|
| (247,767 | ) |
|
| (241,694 | ) |
Total stockholders' equity |
|
| 40,550 |
|
|
| 18,381 |
|
Total liabilities and stockholders' equity |
| $ | 43,621 |
|
| $ | 21,093 |
|
Atomera Incorporated
Condensed Statements of Operations
(in thousands, except per share data)
|
| Three Months Ended |
| |||||||||
|
| March 31, |
|
| December 31, |
|
| March 31, |
| |||
|
| 2026 |
|
| 2025 |
|
| 2025 |
| |||
|
| (Unaudited) |
|
| (Unaudited) |
|
| (Unaudited) |
| |||
Revenue |
| $ | 11 |
|
| $ | 50 |
|
| $ | 4 |
|
Cost of revenue |
|
| (126 | ) |
|
| (131 | ) |
|
| - |
|
Gross profit (loss) |
|
| (115 | ) |
|
| (81 | ) |
|
| 4 |
|
|
|
|
|
|
|
|
|
|
|
|
| |
Operating expenses |
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
| 3,457 |
|
|
| 2,740 |
|
|
| 3,255 |
|
General and administrative |
|
| 2,333 |
|
|
| 1,505 |
|
|
| 2,088 |
|
Selling and marketing |
|
| 419 |
|
|
| 286 |
|
|
| 124 |
|
Total operating expenses |
|
| 6,209 |
|
|
| 4,531 |
|
|
| 5,467 |
|
|
|
|
|
|
|
|
|
|
|
|
| |
Loss from operations |
|
| (6,324 | ) |
|
| (4,612 | ) |
|
| (5,463 | ) |
|
|
|
|
|
|
|
|
|
|
|
| |
Other income (expense) |
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
| 197 |
|
|
| 195 |
|
|
| 270 |
|
Accretion income |
|
| 57 |
|
|
| - |
|
|
| 6 |
|
Interest Expense |
|
| (4 | ) |
|
| (9 | ) |
|
| (21 | ) |
Other income (expense), net |
|
| 1 |
|
|
| 1 |
|
|
| (1 | ) |
Total other income (expense), net |
|
| 251 |
|
|
| 187 |
|
|
| 254 |
|
|
|
|
|
|
|
|
|
|
|
|
| |
Net loss |
| $ | (6,073 | ) |
| $ | (4,425 | ) |
| $ | (5,209 | ) |
|
|
|
|
|
|
|
|
|
|
|
| |
Net loss per common share, basic and diluted |
| $ | (0.17 | ) |
| $ | (0.14 | ) |
| $ | (0.17 | ) |
|
|
|
|
|
|
|
|
|
|
|
| |
Weighted average number of common shares outstanding, basic and diluted |
|
| 35,256 |
|
|
| 31,590 |
|
|
| 30,243 |
|
Atomera Incorporated
Reconciliation to Non-GAAP EBITDA
(Unaudited)
|
| Three Months Ended |
| |||||||||
|
| March 31, |
| December 31, |
|
| March 31, |
| ||||
|
| 2026 |
| 2025 |
|
| 2025 |
| ||||
Net loss (GAAP) |
| $ | (6,073 | ) |
| $ | (4,425 | ) |
| $ | (5,209 | ) |
Depreciation and amortization |
|
| 9 |
|
|
| 13 |
|
|
| 12 |
|
Stock-based compensation |
|
| 1,406 |
|
|
| 1,334 |
|
|
| 1,009 |
|
Interest income |
|
| (197 | ) |
|
| (195 | ) |
|
| (270 | ) |
Accretion income |
|
| (57 | ) |
|
| - |
|
|
| (6 | ) |
Interest expense |
|
| 4 |
|
|
| 9 |
|
|
| 21 |
|
Other (income) expense, net |
|
| (1 | ) |
|
| (1 | ) |
|
| 1 |
|
Net loss non-GAAP EBITDA |
| $ | (4,909 | ) |
| $ | (3,265 |
|
| $ | (4,442 | ) |
Investor Contact:
Bishop IR
Mike Bishop
(415) 894-9633
investor@atomera.com
SOURCE: Atomera, Inc.
View the original press release on ACCESS Newswire
COMTEX_478588100/2457/2026-05-05T16:01:04
